Severity
Moderate
FDA Devices recall · Reported February 22, 2017
Generators may have a faulty component which could impact the proper functioning of the device.
Aesculap Implant Systems LLC recalled GN200 Caiman HF generators, electrosurgical, cutting & coagulation & accessories - a moderate-severity action.
GN200 Caiman HF generators, electrosurgical, cutting & coagulation & accessories was recalled by Aesculap Implant Systems LLC in February 22, 2017. Reason: Generators may have a faulty component which could impact the proper functioning of the device.. Check the official notice for the remedy. Verify recall #Z-1218-2017 with the FDA Devices before acting.
The recall
Aesculap Implant Systems LLC issued this moderate-severity FDA Devices recall-Generators may have a faulty component which could impact the proper functioning of the device..
Sourced from official FDA Devices enforcement records. Verify recall #Z-1218-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-1218-2017) was formally reported on February 22, 2017, with the manufacturer initiating the action on January 9, 2017. It is classified under Moderate severity (Class II), with a current status of Terminated. Aesculap Implant Systems LLC is listed as the recalling firm, operating out of Center Valley, PA. Federal records list the affected scope as 24 generators.
The documented reason for this recall is: Generators may have a faulty component which could impact the proper functioning of the device. Distribution data in the federal record shows the product reached: USA (nationwide Distribution).. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
24 generators
Related Recalls
6
3 from same agency
GN200 Caiman HF generators, electrosurgical, cutting & coagulation & accessories
Generators may have a faulty component which could impact the proper functioning of the device.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-1218-2017 |
| Date reported | February 22, 2017 |
| Date initiated | January 9, 2017 |
| Recalling firm | Aesculap Implant Systems LLC |
| Firm location | Center Valley, PA |
| Affected scope | 24 generators |
| Distribution | USA (nationwide Distribution). |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported February 22, 2017. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.